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Abstract: Parameters of ligand binding, stimulation of low- 
K, GTPase, and inhibition of adenylate cyclase were deter- 
mined in intact human neuroblastoma SH-SYSY cells and 
in their isolated membranes, both suspended in identical 
physiological buffer medium. In cells, the p-selective opioid 
agonist [3H]Tyr-~-Ala-Gly(Me)Phe-Gly-ol ([3H]DAMGO) 
bound to two populations of sites with KD values of 3.9 and 
160 nM, with <lo% of the sites in the high-affinity state. 
Both sites were also detected at 4°C and were displaced by 
various opioids, including quaternary naltrexone. The opioid 
antagonist [3H]naltrexone bound to a single population of 
sites, and in cells treated with pertussis toxin the biphasic 
displacement of [3H]naltrexone by DAMGO became mono- 
phasic with only low-affinity binding present. The toxin spe- 
cifically reduced high-affinity agonist binding but had no effect 
on the binding of [3H]naltrexone. In isolated membranes, 
both agonist and antagonist bound to a single population of 
receptor sites with affinities similar to that of the high-affinity 
binding component in cells. Addition of GTP to membranes 
reduced the B,,, for [3H]DAMG0 by 87% and induced a 
linear ligand binding component; a low-affinity binding site, 
however, could not be saturated. Compared with results ob- 
tained with membranes suspended in Tris buffer, agonist 
binding, including both receptor density and affinity, in the 
physiological medium was attenuated. The results suggest 
that high-affinity opioid agonist binding represents the ligand- 
receptor-guanine nucleotide binding protein (G protein) 
complex present in cells at low density due to modulation 
by endogenous GTP. Opioid receptor coupling to adenylate 
cyclase in intact and fragmented cells occurred with similar 
efficiency: DAMGO inhibited adenylate cyclase with Ki values 
of I 1 nM in cells and 26 nM in lysates, with 30% maximal 
inhibition in both preparations. Receptor coupling to G pro- 
tein in membranes occurred with similar parameters: 
DAMGO stimulated low-K, GTPase with a K, of 31 nM 
and an S,,, of 48%. Both effector responses were blocked by 
naloxone and were strongly impaired by rigorous cell ho- 
mogenization. These results indicate that opioid signal trans- 
duction in intact SH-SYSY cells and their appropriately iso- 
lated membranes functions with similar efficiencies involving 
a large reserve of uncoupled receptors. Key Words: p-Opioid 
receptor--(; protein-Adenylate cyclase-GTPase-SH- 
SYSY cells. Carter B. D. and Medzihradsky F. Opioid signal 
transduction in intact and fragmented SH-SYSY neural cells. 
J. Neurochem. 58, 16 1 1 - 16 1 9 ( 1992). 
Agonist binding to opioid receptor results in the in- 
hibition of adenylate cyclase (Sharma et al., 1975; Law 
et al., 198 l), is mediated by guanine nucleotide binding 
protein (G protein) (Bums et al., 1983; Kurose et al., 
1983), and involves the stimulation of low-&, GTPase 
(Koski and Klee, 198 1 ; Barchfeld and Medzihradsky, 
1984). The high- and low-affinity binding components 
of opioid agonists, in contrast to those of antagonists, 
have been identified as ligand complexes with G pro- 
tein-coupled and free receptors, respectively (Remmers 
and Medzihradsky, 199 la,@. Although these receptor 
mechanisms are well established, diverging character- 
istics for individual steps were obtained in various 
systems, e.g., both monophasic and biphasic binding 
of opioid agonists has been described. Whereas 
the binding of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol 
([3H]DAMGO) in membranes from brain (Werling et 
al., 1985) and SH-SY5Y cells (Kazmi and Mishra, 
1987; Toll, 1990) and of [3H]etorphine in mouse pi- 
tuitary tumor cells and NG108-15 neuroblastoma- 
glioma hybrids (Puttfarcken et al., 1986) was mono- 
phasic, [3H]Tyr-~-Ala-Gly-Phe-~-Leu in NG 108- 15 
cells (Costa et al., 1985) and [3H]DAMG0 in SH-SYSY 
cells (Fig. 1) bound to two populations of receptor sites. 
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FIG. 1. Scatchard plots of opioid receptor binding in intact SH- 
SY5Y cells. Results of homologous displacement of [3H]DAMG0 
(upper panel) and saturation binding of [3H]naltrexone at equilibrium 
(lower panel) in physiological buffer at 37 (0) and 4°C (A) are 
shown. Inset: Homologous displacement data as the percentage 
of [3H]DAMG0 bound versus increasing concentrations of unla- 
beled DAMGO. Results of representative experiments replicated 
two to five times are shown. The corresponding binding parameters 
and statistical information are listed in Table 1. 
It is particularly difficult to reconcile the differences in 
the kinetic parameters of opioid ligand-receptor-ef- 
fector interactions obtained in isolated membranes and 
intact cells. For example, monophasic binding of 
[3H]Tyr-~-Ala-Gly-Phe-~Leu was described in ho- 
mogenates of NG108-15 hybrids (Costa et al., 1988), 
but biphasic interaction in the whole cells (Costa et al., 
1985). Interpretation of opioid binding in intact cells 
is made difficult by possible ligand-receptor internal- 
ization (Blanchard et al., 1983), intracellular opioid 
receptors (Roth et al., 1981), and existence of nono- 
pioid binding sites (Schweigerer et al., 1985). 
Disparity between intact cells and isolated mem- 
branes has also been described for receptor-effector 
coupling: The ICso for opioid inhibition of adenylate 
cyclase was higher in isolated membranes than in whole 
cells (see, e.g., Costa et al., 1988). The efficiency of 
opioid receptor-effector coupling, assessed by the ratio 
of ligand binding affinity to the extent of effector re- 
sponse, was different in various whole and fragmented 
cells, respectively: KD/ICso ratios of 1 (Creese and Sny- 
der, 1975; Carroll et al., 1988), t l  (Puttfarcken et al., 
1986; Costa et al., 1988), and > 1  (Law et al., 1983) 
were reported. 
The above-outlined discrepancies in ligand binding 
and receptor coupling are largely unresolved and con- 
tribute to the existing gap in relating information ob- 
tained with isolated membranes to opioid function ob- 
served in intact cells or whole animals. The importance 
of comparing receptor mechanisms in whole and frag- 
mented cells has also been recognized in other receptor 
systems, e.g., the adrenergic (Porzig, 1982; Sladeczek 
et al., 1983; Staehelin et al., 1983). Therefore, the pres- 
ent investigation was undertaken to examine the in- 
teractions among ligand, receptor, and effector com- 
ponents in intact SH-SYSY neural cells and their iso- 
lated membranes under identical experimental 
conditions, using both simple and physiological buffer 
media. The receptor binding of opioid agonist and an- 
tagonist, stimulation of low-K, GTPase, and inhibition 
of adenylate cyclase were quantified. Preliminary find- 
ings of this work have been presented (Carter and 
Medzihradsky, 1990). 
MATERIALS AND METHODS 
Materials 
The unlabeled opioids were obtained through the Narcotic 
Drug and Opioid Peptide Basic Research Center at the Uni- 
versity of Michigan (Ann Arbor, MI, U.S.A.). 13H]DAMG0 
(60 Ci/mmol), [Y-’~P]GTP (30 Ci/mmol), and the cyclic AMP 
(CAMP) assay kit were purchased from Amersham (Arlington 
Heights, IL, U.S.A.). [’HINaltrexone was kindly provided by 
the National Institute on Drug Abuse. Dulbecco’s modified 
Eagle’s medium and fetal bovine serum were purchased from 
GIBCO Laboratories (Grand Island, NY, U.S.A.). Other bio- 
chemicals, including pertussis toxin, were obtained from 
Sigma Chemical Co. Human neuroblastoma SH-SY5Y cells, 
originating from Dr. June L. Biedler (Memorial Sloan-Ket- 
tering Cancer Center, New York, NY, U.S.A.), were a gen- 
erous gift from Dr. S. K. Fisher (Department of Pharmacol- 
ogy, University of Michigan). 
Cell culture 
The SH-SY5Y cells (passage 79-85) were grown for 7-20 
days in Dulbecco’s modified Eagle’s medium containing 10% 
fetal bovine serum, in tissue culture flasks or 35-mm-diameter 
polystyrene plates as described (Fisher and Snider, 1987). In 
all experiments with intact cells, their viability was ascertained 
by measuring the cellular K+/Na+ ratio (Fischel and Med- 
zihradsky, 1985). Under all experimental conditions a ratio 
of 2 3  was obtained, indicative of intact cells with an unper- 
turbed plasma membrane (Medzihradsky and Marks, 1975). 
Membrane isolation 
All experiments were camed out with freshly prepared 
membranes. The surface-growing cells were rinsed twice with 
phosphate-buffered saline (154 mM NaCl, 0.61 mM 
Na2HP04, and 0.38 mMKH2PO4, pH 7.4) and then removed 
from the flask surface by incubation with a Ca2+, Mg2+-free 
modified Puck’s solution for 10 min (Honegger and Richel- 
son, 1976). The suspension was centrifuged for 5 min at 200 
g, and the pellet was suspended in hypotonic buffer (0.61 
mMNa,HP04, 0.38 mMKH2P04, 0.2 mMMgS04, and 1 
mM dithiothreitol, pH 7.4) and gently dispersed in a Dounce 
homogenizer. This suspension was centrifuged for 15 min at 
20,000 g and 4OC, and the pellet was dispersed with the hy- 
potonic buffer described above or with 50 mMTris-HC1 (pH 
7.4) at a protein concentration of 1-2 mg/ml. 
For some experiments the cells were harvested into buffer 
A ( 1  28 mM NaCl, 2.4 mM KCl, 2.0 mM NaHC03, 3.0 mM 
MgS04, 10 mMNa2HP04, 1.3 mMCaClz, 10 &glucose, 
and 8 mM theophylline, pH 7.4 at 37°C) and homogenized 
at a 1:lOO dilution using a Brinkmann Polytron (model PT 
10; setting of 6.5) for 1 min. 
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Ligand binding 
Ligand binding in isolated membranes was camed out as 
described previously (Fischel and Medzihradsky, 198 I;  Clark 
et al., 1988). In brief, the assay medium contained 100 p1 of 
the membrane suspension (100-200 pg of protein), 300 pl 
of buffer (either buffer A to give the final concentrations de- 
scribed above or 50 mM Tris-HC1, pH 7.4), 50 pl of water 
(containing in some experiments GTP or NaCl to give final 
concentrations of 10 pM and 150 mM, respectively), 50 pl 
of unlabeled opioid, and 25 p1 of radiolabeled ligand. Specific 
binding was determined with 20 pM DAMGO or 2 pM nal- 
trexone, respectively, concentrations shown to give maximal 
displacement of the radioligands used. In displacement ex- 
periments 2 IUW[~H]DAMGO or 0.5 nM[3H]naltrexone was 
used, whereas the concentration of unlabeled opioid varied. 
After a 15-min preincubation, the assay was initiated by ad- 
dition of radiolabeled and unlabeled ligand. Following in- 
cubation to achieve ligand binding equilibrium at 37°C (80 
rnin for [3H]DAMG0, 30 rnin for [3H]naltrexone), the sam- 
ples were quickly filtered and subjected to liquid scintillation 
counting as described. 
For determination of ligand binding in intact cells, they 
were first rinsed with phosphate-buffered saline and lifted 
from the flask surface as described above. The cells were then 
pelleted (5 min, 200 g) and resuspended in buffer A at a 
protein concentration of 0.5 mg/ml, corresponding to -2.4 
X lo6 cells/ml. Aliquots (400 pl) of this suspension were in- 
cluded in the receptor assay described above. In some ex- 
periments, before ligand binding the cells were exposed to 
pertussis toxin at 80 ng/ml of medium for 5 or 12 h. 
Adenylate cyclase assay 
The assay of enzyme activity in isolated membranes was 
based on the procedure described by Olasmaa and Terenius 
(1988). In a final volume of 100 pl the assay medium con- 
tained 50 p1 of membrane suspension (40-70 pg of protein), 
10 pl of a mixture of GTP (final concentration, 10 p M )  and 
opioid ligand, and 40 pl of buffer (final concentrations iden- 
tical to those of buffer A with the addition of 1 mM ATP 
and 1 mM ouabain). Creatine phosphate and creatine kinase 
were added fresh to the buffer medium to give final concen- 
trations of 20 mM and 3 U per tube, respectively. The assay 
was initiated by addition of membranes to the prewarmed 
buffer medium and, after incubation for 10 rnin at 37"C, 
was terminated by addition of 50 pI of 0.15 M HCI. At this 
point, the samples were frozen and kept at -20°C until cAMP 
analysis. After thawing and neutralization with Tris base, al- 
iquots were subjected to quantification of cAMP using a ra- 
dioligand binding assay kit from Amersham. 
For measurement of adenylate cyclase activity in intact 
cells, SH-SY5Y neurons grown to confluency in 35-mm-di- 
ameter plates were aspirated free of culture medium, rinsed 
three times with phosphate-buffered saline, and incubated 
for 30 rnin at 37°C in buffer A. Subsequently, the medium 
was replaced with 1.5 ml of buffer A containing 43 pM pros- 
taglandin Ez (added to raise the level of CAMP and, thus, the 
sensitivity of the assay) with or without DAMGO. After 15 
rnin at 37"C, the reaction was terminated by aspiration of 
the buffer medium and addition of 1 ml of 0.05 M HCI. The 
cells were then scraped off the plates with 2 ml of water and 
frozen at -20°C. After thawing, the suspension was centri- 
fuged at 20,000 g for 15 min, and the supernatant was neu- 
tralized with Tris base and subjected to quantification of 
cAMP using the Amersham kit. The remaining membrane 
pellets were dissolved in 1 M NaOH for the determination 
of protein content. 
GTPase assay 
With minor modifications, the method described previ- 
ously was used (Clark and Medzihradsky, 1987). In brief, the 
assay medium consisted of 30 p1 of membrane suspension, 
40 1 1  of the buffer described above for the adenylate cyclase 
assay (also containing 5'-adenylylimidodiphosphate to give a 
final concentration of 1 mM), 20 p1 of GTP solution (final 
concentration, 2 pM, composed of 1.5 pM unlabeled and 
0.5 pM [T-~~PIGTP), and 10 pl of water or DAMGO solution. 
In separate tubes the opioid-insensitive, high-K, GTPase ac- 
tivity was measured in the presence of 50 pM GTP. The 
assay was initiated by addition of membrane suspension to 
the prewarmed buffer medium. After incubation for 10 min 
at 37"C, the liberated 32P was separated from the nucleotide 
by charcoal treatment and subjected to liquid scintillation 
counting as described. 
Quantification of protein 
The method of Lowry et al. (1 95 1) was used, with bovine 
serum albumin as the standard. For determination of the 
protein concentration in intact cells, the cell suspension was 
initially disrupted by sonication for 30 s (Heatsystems- 
Ultrasonics; model W-385 with microtip; setting of 3.5), 
and the protein was solubilized with 0.2 M NaOH for 1 h 
at 37°C. 
Data analysis 
Homologous displacement and saturation data were fitted 
to a one- and two-site model with or without a linear binding 
component by nonlinear regression analysis using the NON- 
LIN module ofthe computer program SYSTAT (Wilkinson, 
1988). The results of multiple experiments were analyzed 
together, and all reported data are based on regressions for 
which the distribution of residuals was random and normal. 
The best fit to a given model was determined using the F- 
ratio test to compare the weighted residual sum of squares 
with p > 0.05. The corresponding SEM was computed within 
NONLIN from the residual sum of squares of the regression. 
To account for variations in receptor density between different 
preparations of SH-SY5Y cells, an appropriate correction 
factor was calculated as described for the binding program 
LIGAND (Munson and Rodbard, 1980). The results of het- 
erologous displacement were fitted to one- and two-site mod- 
els using the computer program LIGAND. The parameters 
listed are those obtained from the best fit according to the 
F-ratio test where p > 0.05 and for which a random, normal 
distribution of variance was observed. 
Inhibition of adenylate cyclase and stimulation of low-K, 
GTPase were expressed as Ki and Z, (maximal inhibition) 
and K, (ligand concentration for half-maximal stimulation) 
and S,, (maximal stimulation), respectively. The data were 
subjected to nonlinear least squares analysis using the com- 
puter program GraphPad (IS1 Software, Philadelphia, PA, 
U.S.A.). The values for K,, Z,, K,, and S, were determined 
by fitting all the data obtained from multiple experiments to 
a sigmoidal function: Y = B/[ 1 + (lox/] 0 9 9 ,  where Y is the 
percent stimulation or inhibition, X is the logarithm of the 
ligand concentration, B is the maximum of the curve (I,,, 
or S,,,), C is the logarithm of ligand Concentration at the 
half-maximum of the curve (log ECso, Ki, or Ks), and D is 
the slope factor. 
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TABLE 1. Parameters of ligand binding in whole cells 
KD B,, (fmol/mg of protein) 
T 
Experiment ("C) Site 1 Site 2 Site I Site 2 n 
~~ ~ 
[3H]DAMG0 
Saturation 37 2.5 k 0.7 ND 25 f 3 ND 62 ( 5 )  
Displacement 37 3.9 f 1.4 161 f 29 34 _t 9 527 ? 135 86 (4) 
Displacement 4 10.2 ? 4.4 158 f 32 37 & 17 133 ? 58 67 (3) 
Saturation 37 1.1 k O . 1  ND 252 f 7" ND 36 (3) 
Saturation 4 0.3 2 0.04 ND 361 f 18 ND 20 (2) 
[3H]Naltrexone 
The parameters shown were obtained from nonlinear regression analysis using the program SYSTAT and considering binding models with 
one site, two sites, and one site and one linear binding component. The best fit was determined by comparison of the weighted residual sum 
of squares as described in Materials and Methods. Data are mean f SEM values from the number of observations indicated (no. of experiments). 
ND, not detected; T, temperature. 
Aspects to be considered in comparing receptor density in intact cells and isolated membranes as described in Results. 
RESULTS 
Ligand binding in whole cells 
Saturation binding of ['HIDAMGO at equilibrium 
depicted a single population of binding sites (Table l), 
but homologous displacement of ['HI DAMGO by high 
concentrations of the unlabeled opioid demonstrated 
biphasic ligand binding (Fig. 1 and Table 1). Saturation 
of the low-affinity sites with radiolabeled ligand was 
not feasible owing to high levels of nonspecific binding. 
In such cases, as shown previously with opioid receptor 
binding in brain slices (Barchfeld-Rothschild and 
Medzihradsky, 1985), homologous displacement (Fig. 
1, inset) offers an alternative to direct saturation bind- 
ing. Various opioids, including both peptide and al- 
kaloid agonists, were able to displace >95% of specif- 
ically bound ['HIDAMGO, indicating the opioid na- 
ture of sites recognized by the peptide (Fig. 2 and Table 
2). In addition, the high-affinity K, for levorphanol 
was -2,000-fold lower than that for its stereoisomer 
dextrorphan, demonstrating stereospecificity of the 
['HIDAMGO binding sites. Whereas the antagonist 
naltrexone displaced [3H]DAMG0 monophasically, 
displacement with the agonists levorphanol or PL017 
was biphasic, suggesting receptor-(; protein coupling 
(Fig. 2 and Table 2). Treatment of the cells with per- 
tussis toxin for 5 h reduced, and for 12 h eliminated, 
high-affinity [ 'HIDAMGO binding without altering 
the low-affinity component, whereby neither affinity 
was significantly altered by the toxin (Table 3). The 
toxin did not change the amount of antagonist 
binding, but rather altered the biphasic displacement 
of [3H]naltrexone by DAMGO: After treatment with 
pertussis toxin for 12 h only monophasic, low-affinity 
binding was detected (Table 3). 
To investigate possible internalization of [3H] 
DAMGO, its displacement by quaternary naltrexone 
was assessed. This charged molecule does not penetrate 
biological membranes and should therefore only rec- 
ognize binding sites on the cell surface (Valentino et 
al., 198 1). Quaternary naltrexone displaced all specif- 
ically bound [3H]DAMG0 in intact SH-SY5Y cells 
TABLE 2. Heterologous displacement of ('H]DAMGO 
in whole cells 
Displacer Site 1 Site 2 n 
Levorphanol 1.8 f 1.0 43 f 37 76(4) 
Dextrorphan 3,640 -t 450 ND 28 (2) 
PLO 17" 31.0 f 12.3 880 2 620 74 (4) 
Naltrexone 0.4 i 0.03 ND 38 (2) 
Quaternary naltrexone 29.3 f 5.0 ND 34 (2) 
-10 -6 -6 - 4  
LOG IOISPLACING LIGANOl 
FIG. 2. Displacement of [3H]DAMG0 by opioids in intact cells. The 
inhibition of specific binding of 2 nM t3H]DAMG0 in physiological 
buffer at  37°C by levorphanol (O), dextrorphan (+), PL017 (A), 
naltrexone (m), and quaternary naltrexone (0) is shown. Data are 
mean values obtained in two to four experiments. The correspond- 
ing parameters and statistical information are listed in Table 2. 
~~ ~ 
The parameters shown were obtained from nonlinear regression 
analysis using the program LIGAND and considering models with 
one and two sites. The best fit was determined on the basis of an F- 
ratio test as described in Materials and Methods. Data are mean 
f SEM values from the number of observations indicated (no. of 
experiments). ND, not detected. 
Tyr-Pro-(Me)Phe-D-Pro-NH2, a p-selective opioid (Chang et a]., 
1983). 
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TABLE 3. Effects of pertussis toxin on ligand binding in whole cells 
KD (a) B ,  (fmol/mg of protein) 
Initial binding, 
displacer Pertussis Site 1 Site 2 Site 1 Site 2 n 
3.5 * 1 . 1  118+-77  16 It 4.3 99 f 38 66 (3) 
85 2 27 3.4 2 3.2 99 f 87 56 (3) 




DAMGO + 2.3 2 3.0 
['H]Naltrexone 
- DAMGO 
DAMGO + ND 850 * 590 ND 200 k 89 56 (2) 
SH-SY5Y cells were incubated without (-) and with (+) pertussis toxin at 80 numl of medium for 5 h (binding of ['HIDAMGO) or 12 h 
(binding of ['Hlnaltrexone). Subsequently, either homologous displacement of [3H]DAMG0 or displacement of ['Hlnaltrexone by DAMGO 
was carried out as described in Materials and Methods. The parameters shown were obtained from nonlinear regression analysis using the 
program SYSTAT (displacement of ['HIDAMGO) or LIGAND (displacement of ['H]naltrexone), considering binding models with one site or 
two sites with or without a linear component. The best fit was determined by comparison of the weighted residual sum of squares. Data are 
mean ? SEM values from the number of observations indicated (no. of experiments). ND, not detected. 
(Fig. 2). Cell surface binding of [3H]DAMG0 was fur- 
ther supported by experiments carried out at 4°C: Un- 
der these conditions ['HIDAMGO still exhibited two 
binding components with similar parameters, except 
for the reduced B,, of the low-affinity site (Table 1). 
In contrast to ['HI DAMGO, the opioid antagonist 
[3H]naltrexone bound to a single population of receptor 
sites (Fig. 1 and Table 1). Its B,,, of 252 fmol/mg of 
protein corresponds to - 32,000 receptors per cell, in 
general agreement with the receptor density on the 
parent cell line, SK-N-SH (Yu et al., 1986). At 4°C the 
binding of ['Hlnaltrexone was also monophasic (Ta- 
ble 1). 
Ligand binding in isolated membranes 
Under conditions identical to those used in the ex- 
periments with intact cells, i.e., physiological medium 
at 37"C, ['HIDAMGO bound to a single site (Fig. 3 
and Table 4). However, in contrast to whole cells, ho- 
mologous ligand displacement failed to reveal addi- 
tional low-affinity binding sites for ['HIDAMGO: The 
data obtained best fit a single-site model, which cor- 
responded well with the binding parameters of 
['HIDAMGO obtained in saturation experiments (Ta- 
ble 4). Whereas low temperature increased the B,, of 
['HIDAMGO, addition of GTP reduced it by up to 
87% without altering the best fit to a model of one 
population of sites (Fig. 3 and Table 4). To assess the 
influence of the physiological medium, opioid receptor 
binding of ['HIDAMGO was also determined in cell 
membranes suspended in Tris buffer. In this system 
both binding affinity and density of sites were higher 
than those obtained in the physiological medium (Fig. 
3 and Table 4). 
The main characteristics of [ 'Hlnaltrexone binding 
in membranes were the marginal effect of GTP, the 
increased binding affinity at 4°C [also observed with 
brain membranes (Fischel and Medzihradsky, 198 l)], 
and the reduced B,, in physiological medium com- 
pared with that in Tris buffer (Fig. 3 and Table 4). It 
should be noted that the density of receptors in frag- 
mented and intact cells is not directly comparable be- 
cause ligand binding in cells was expressed on the basis 
of whole-cell protein. During membrane isolation 
-42% of cell protein was lost. Thus, the B,,, of 252 
fmol/mg of whole-cell protein for ['Hlnaltrexone has 
to be corrected to 434 fmol/mg of membrane protein, 
0, "0 150 300 450 
E --. 
0 150 300 450 
ROUND lfnol/ng protein1 
FIG. 3. Scatchard plots of opioid receptor binding in isolated SH- 
SY5Y membranes. Results of saturation binding at equilibrium of 
(A and 9) r3H]DAMG0 and (C) [3H]naltrexone at 37°C in physio- 
logical medium (circles) or Tris-HCI (pH 7.4; .) in the presence (0) 
or absence (a) of 10 f l  GTP are shown. Antagonist binding in 
Tris buffer was determined in the presence of 150 mM NaCI. Rep- 
resentative experiments replicated two to five times are shown. 
The corresponding binding parameters and statistical information 
are listed in Table 4. 
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TABLE 4. Parameters of opioid binding in isolated membranes 
T B,, 












































7.0 f 0.4 
10.1 t 0.5 
12.5 f 5.7 
24.3 f 8.5 
15.1 f 1.0 
1.0 ? 0.04 
0.7 f 0.09 
1.0 * 0.1 
0.2 -t 0.01 
0.7 t 0.03 
0.2 -+ 0.01 
142 ? 4 
201.2 rt 5 
1 8 + 9  
69 * 25 
470 * 16 
469 f 7 
299 f 16 
348 + 17 
330 k 3 
449 .+ 9 
431 + 9  
The parameters shown were obtained from nonlinear regression analysis using the program SYSTAT and considering binding models with 
one site, two sites, and one site and one linear binding component. The best fit was determined by the F-ratio test as described in Materials 
and Methods. Some experiments were camed out in the presence of 10 pMGTP. Data are mean * SEM values from the number of observations 
indicated (no. of experiments). T, temperature. 
' Buffer A denotes the physiological medium described in Materials and Methods, whereas Tris refers to 50 mM Tris-HC1, pH 7.4. 
in agreement with the value of 450 fmol/mg deter- 
mined. 
Receptor-effector coupling in whole cells 
As shown in Fig. 4, DAMGO inhibited the prosta- 
glandin E2-stimulated formation of CAMP with a Ki of 
1 1.2 f 2.9 nM and ZmaX of 33.1 f 2.0% (mean f SEM, 
n = 7). The inhibition was mediated by the p-opioid 
receptor: The effect was blocked by 10 pM naloxone 
but not by the same concentrations of the 6-selective 
antagonist ICI- 174,864 (data not shown). 
Receptor-effector coupling in isolated membranes 
In cell membranes suspended in physiological me- 
dium the characteristics of adenylate cyclase inhibition 
by DAMGO were similar to those observed in intact 
cells, with values (mean f SEM, n = 6) for Ki and I,,, 
of 25.8 & 4.8 nM and 27 & 1.0%, respectively (Fig. 4). 
In addition, DAMGO stimulated low-K,,, GTPase ac- 
tivity with an S,,, (+. SEM, n = 4) of 47.6 f 3.8% and 
a K, of 3 1.5 * 8.6 nM, a value quite similar to the K, 
for inhibition of adenylate cyclase. Both opioid-stim- 
ulated GTPase activity and the inhibition of adenylate 
cyclase were completely inhibited by 10 pM naloxone 
but were insensitive to ICI-174,864. 
The efficiency of receptor-effector coupling was de- 
pendent on the mode of membrane isolation. In the 
experiments described above the membranes were ob- 
tained by hypotonic lysis of the cells, followed by a 
gentle dispersion in a Dounce homogenizer, and were 
used immediately. However, if the cells were homog- 
enized in a Brinkmann Polytron, the K, for GTPase 
stimulation by DAMGO increased to 98.8 f 6.5 nM 
(mean f SEM, n = 6), at similar Smm. Furthermore, 
such vigorous treatment reduced the opioid receptor- 
mediated inhibition of adenylate cyclase to < 10%. The 
harsh homogenization of cells primarily affected re- 
ceptor-effector coupling because the basal activity of 
adenylate cyclase following either treatment was un- 
changed: 30.2 f 7.3 pmol of cAMP/min/mg of protein 
in hypotonic lysates and 29.5 + 6.5 pmol of CAMP/ 
min/mg of protein in Polytron-disrupted membranes. 
DISCUSSION 
Although direct saturation binding of [3H]DAMG0 
in intact SH-SY5Y cells indicated the presence of a 
single population of sites with high affinity, both ho- 
mologous and heterologous displacement of the radio- 
ligand by higher concentrations of opioid agonists re- 
vealed additional sites of lower affinity. In contrast, the 
opioid antagonist naltrexone bound to a single popu- 
lation of sites, and its displacement of bound 
[ 3H]DAMG0 was monophasic. This differential res- 
olution of [3H]DAMG0 binding by opioid agonists 
and antagonists suggests the involvement of receptor- 
G protein coupling as the underlying mechanism. It 
has recently been shown that high-affinity opioid ag- 
onist binding in brain membranes reflects the ligand- 
occupied receptor-G protein complex (Remmers and 
Medzihradsky, 1991a). The presence in intact cells of 
G protein-coupled and -uncoupled p-opioid receptors 
was strongly supported by experiments with pertussis 
toxin, which uncouples the receptor by catalyzing the 
covalent modification of Gi inhibitory G proteins (Ku- 
rose et al., 1983). Treatment of the cells with the toxin 
for 5 h reduced high-affinity agonist binding by 80%. 
Furthermore, in cells exposed to the toxin for 12 h the 
biphasic displacement of t3H]naltrexone by DAMGO 
became monophasic, representing a shift from high- 
to low-affinity binding, whereby antagonist bind- 
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FIG. 4. Receptor-effector coupling in intact and fragmented SH- 
SYSY cells. DAMGO stimulation of low-K,,, GTPase in cell lysates 
(upper panel) and inhibition of adenylate cyclase (lower panel) in 
lysates (0) and intact cells (0, all suspended in physiological buffer 
at 37"C, are shown. Data are mean k SEM (bars) values (where 
indicated) from four to seven experiments. The curves were drawn 
according to nonlinear regression analysis as described in Materials 
and Methods, and the parameters describing the curves are listed 
in Results. 
ing remained unaltered. The biphasic binding of 
[3H]DAMG0 in intact cells at 4"C, carried out to in- 
hibit endocytosis, and its complete displacement by 
quaternary naltrexone provided evidence against ligand 
internalization as an involved process. The recent re- 
port of DAMGO binding to one site in SH-SYSY cells 
(Toll, 1990) might be the result of using ligand con- 
centrations that were too narrow to discern two affinity 
states with widely diverging KD values. 
In isolated SH-SYSY membranes suspended in 
physiological medium at 37"C, [3H]DAMG0 bound 
to a single population of sites with a KD similar to that 
of the high-affinity site observed in intact cells. Because 
low-affinity agonist binding represents interaction with 
the uncoupled form of the receptor brought about by 
GTP and its nonhydrolyzable analogues (Remmers and 
Medzihradsky, 199 1 a), the removal of guanine nu- 
cleotides during membrane isolation is likely to shift 
the receptors largely into a coupled, high-affinity state. 
Indeed, the addition of GTP to membranes strongly 
reduced the binding of [3H]DAMG0. In membranes 
suspended in Tris buffer such attenuation of opioid 
agonist binding by GTP is much less pronounced 
(Kazmi and Mishra, 1987). Apparently, the effect of 
guanine nucleotides on opioid receptor binding in a 
physiological buffer medium reflects the modulation 
occurring in whole cells. Although the binding of 
[3H]DAMG0 in the presence of GTP had a significant 
linear component, the data could not be adequately 
fitted to a two-site model. This may indicate the pres- 
ence of low-affinity sites that are below the limit of 
detection owing to increasing nonspecific binding at 
high ligand concentration. Such sites, however, would 
have to have an affinity below that seen in cells. As 
expected, binding of [3H]naltrexone was unaltered by 
GTP, and its high B,, indicated that some of the re- 
ceptor sites recognized by the antagonist were unde- 
tected by [3H]DAMG0. In rat brain membranes, the 
equilibrium binding of [ 3H]naltrexone yields biphasic 
Scatchard plots (see, e.g., Fischel and Medzihradsky, 
1981). It has recently been shown that the low-affinity 
component of that binding reflects the interaction of 
naltrexone with 8-opioid receptors (Remmers and 
Medzihradsky, 199 lb). Because the majority of opioid 
receptors on the SH-SYSY cells are the p type (Yu and 
Sadee, 1988), low-affinity binding to 8 receptors was 
undetectable below 15 nM, the highest concentration 
of ['Hlnaltrexone used in the saturation experiments. 
In the physiological medium the properties of opioid 
ligand binding were quite different from those obtained 
in Tris buffer. Whereas a decrease in binding affinity 
was limited to [3H]DAMG0, attenuation of B,, was 
also observed for [3H]naltrexone. Apparently the ex- 
tracellular iopk milieu, resembling that in vivo, mod- 
ulates opioid binding by reducing the number of avail- 
able receptor sites as the result of divalent cation action 
(Paterson et al., 1986) and by decreasing the affinity 
of agonist binding to the antagonist receptor confor- 
mation prevailing in the presence of sodium (Pert and 
Snyder, 1974; Nijssen and Childers, 1987). In the 
course of assessing the influence of temperature on 
opioid binding, it was observed that in isolated mem- 
branes, suspended in physiological buffer at 4"C, the 
B,, of [3H]DAMG0 was increased relative to that 
determined at 37 "C. The measured receptor density 
of 470 fmol/mg of protein agrees remarkably well with 
that seen with [3H]DAMG0 at 37°C in Tris buffer and 
with [3H]naltrexone in Tris buffer plus sodium at 37 
and 4°C. This effect may reflect enhanced opioid re- 
ceptor coupling to G protein in the physiological me- 
dium at 4"C, resulting in increased high-affinity agonist 
binding and an elevated B,,, for [3H]DAMG0. Fa- 
cilitated receptor-(; protein coupling at low temper- 
atures has been reported for the muscarinic receptor 
(Aronstam and Narayanan, 1988). 
Of particular significance for this investigation was 
the concurrent assessment of three components of the 
opioid receptor-effector system under identical exper- 
imental conditions, i.e., ligand binding and receptor 
coupling to G protein and adenylate cyclase. 
The functional assays indicated that, in contrast to 
other cellular systems (Costa et al., 1988), the efficiency 
of receptor coupling to adenylate cyclase can be quite 
similar in whole cells and isolated membranes. How- 
ever, the coupling mechanism was found to be very 
sensitive to the method of membrane isolation, an ob- 
servation that may account for some of the reported 
disparities in the characteristics of receptor-effector 
coupling. A quantitative assessment of the latter process 
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is obtained by comparing receptor binding affinity with 
the ligand concentration required to produce half- 
maximal effector response, ie., KD/Ki for adenylate cy- 
clase or KD/Ks for low-K, GTPase. The KD/Ki ratio in 
intact SH-SYSY cells (considering the high-affinity KD) 
was 0.35. Using the appropriate constants for isolated 
membranes virtually the same ratio is obtained. Fur- 
thermore, the ratio of KD/Ks was also 0.32. These re- 
lationships indicate that in SH-SYSY cells, signal 
transduction from the opioid receptor via G protein 
to adenylate cyclase is similar and of relatively low 
efficiency. However, if the low-affinity KD is considered, 
a ratio of 14 is obtained, indicative of a receptor reserve. 
To achieve a half-maximal effector response for either 
cells or their lysates, -70% of the opioid receptors in 
the high-affinity state must be occupied. For the cou- 
pling of opioid receptors to both G protein (Clark et 
al., 1989) and adenylate cyclase (Fantozzi et al., 1981), 
a large receptor reserve was described. In membrane 
binding assays without GTP, most of the receptors are 
in the high-affinity, coupled state. In contrast, in func- 
tional assays requiring GTP and Na’ (Blume et al., 
1979), the receptors will be predominantly in an un- 
coupled state. The findings presented here indicate that 
under conditions that mimic those in vivo, i.e., intact 
cells, or membranes in physiological medium with 
GTP, only a small fraction of the receptor population 
is coupling to the investigated effectors, and thus most 
of the receptors are nonfunctional or “spare.” 
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